MX345029B - Composiciones inmunogénicas y métodos de uso. - Google Patents

Composiciones inmunogénicas y métodos de uso.

Info

Publication number
MX345029B
MX345029B MX2014006929A MX2014006929A MX345029B MX 345029 B MX345029 B MX 345029B MX 2014006929 A MX2014006929 A MX 2014006929A MX 2014006929 A MX2014006929 A MX 2014006929A MX 345029 B MX345029 B MX 345029B
Authority
MX
Mexico
Prior art keywords
immunogenic compositions
methods
surface adsorption
regions
polyelectrolytes
Prior art date
Application number
MX2014006929A
Other languages
English (en)
Inventor
Templeton Haynie Donald
Original Assignee
Artificial Cell Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artificial Cell Tech Inc filed Critical Artificial Cell Tech Inc
Publication of MX345029B publication Critical patent/MX345029B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Composite Materials (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laminated Bodies (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

La presente invención se refiere a composiciones inmunogénicas que comprenden una película multicapa que comprende dos o más capas de polielectrolitos, donde las capas adyacentes comprenden polielectrolitos con carga opuesta. Un polielectrolito de una primera capa que comprende un polipéptido antigénico que comprende una o más regiones de adsorción de superficie unidos covalentemente a una o más regiones determinantes antigénicos, donde el polipéptido antigénico y una o más regiones de adsorción de superficie tienen la misma polaridad. Las composiciones inmunogénicas pueden emplearse en métodos para producir una respuesta inmunitaria en un organismo vertebrado.
MX2014006929A 2005-10-25 2006-10-25 Composiciones inmunogénicas y métodos de uso. MX345029B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72982805P 2005-10-25 2005-10-25
PCT/US2006/041666 WO2007050702A2 (en) 2005-10-25 2006-10-25 Immunogenic compositions and methods of use

Publications (1)

Publication Number Publication Date
MX345029B true MX345029B (es) 2017-01-13

Family

ID=37946304

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014006929A MX345029B (es) 2005-10-25 2006-10-25 Composiciones inmunogénicas y métodos de uso.
MX2008005364A MX2008005364A (es) 2005-10-25 2006-10-25 Composiciones inmunogenicas y metodos de uso.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2008005364A MX2008005364A (es) 2005-10-25 2006-10-25 Composiciones inmunogenicas y metodos de uso.

Country Status (11)

Country Link
US (6) US20080020402A1 (es)
EP (3) EP1948695B1 (es)
JP (2) JP5751741B2 (es)
CN (3) CN101365724A (es)
AU (2) AU2006347951B2 (es)
CA (2) CA2632703A1 (es)
DK (2) DK2308900T3 (es)
ES (2) ES2462519T3 (es)
IL (2) IL190863A (es)
MX (2) MX345029B (es)
WO (3) WO2008030253A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011526186A (ja) * 2008-06-26 2011-10-06 ボストン サイエンティフィック サイムド，インコーポレイテッド 荷電材料を含む医療機器コーティング
JP4881408B2 (ja) * 2009-05-13 2012-02-22 株式会社バッファロー ネットワーク装置
US9428849B2 (en) 2010-06-21 2016-08-30 University Of South Florida Polypeptide electrospun nanofibrils of defined composition
DK2590675T3 (en) * 2010-07-07 2018-10-29 Artificial Cell Tech Inc ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS
US9513799B2 (en) 2011-06-05 2016-12-06 Apple Inc. Devices, methods, and graphical user interfaces for providing control of a touch-based user interface absent physical touch capabilities
EP2742134A2 (en) 2011-08-11 2014-06-18 Qiagen GmbH Cell- or virus simulating means comprising encapsulated marker molecules
CN104105965B (zh) 2011-11-21 2016-07-06 爱贝斯股份有限公司 侧向流和相关免疫测定中的信号放大
US9116611B2 (en) 2011-12-29 2015-08-25 Apple Inc. Devices, methods, and graphical user interfaces for providing multitouch inputs and hardware-based features using a single touch input
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9433671B2 (en) * 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2014153262A1 (en) * 2013-03-14 2014-09-25 Sevident, Inc. Molecular nets on solid phases
CA2922018C (en) * 2013-09-26 2018-01-16 Jfe Steel Corporation Alloy steel powder for powder metallurgy and method of producing iron-based sintered body
CN105246186A (zh) * 2014-07-08 2016-01-13 苏州卓能微电子技术有限公司 一种led驱动芯片输出电流的精确控制技术
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
WO2016133862A1 (en) * 2015-02-16 2016-08-25 University Of Maryland, College Park Polyelectrolyte multilayers assembled from immune signal compounds
US9961239B2 (en) 2015-06-07 2018-05-01 Apple Inc. Touch accommodation options
CN104846449B (zh) * 2015-06-15 2017-11-28 方贞祥 一种基于层层自组装的仿蜘蛛丝纤维
PT3331818T (pt) 2015-08-04 2024-08-30 Zoetis Services Llc Amplificação de sinal em ensaios de parceiro de ligação específica plasmónicos à base de solução
AU2016322544B2 (en) 2015-09-16 2022-08-25 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
MX2018004854A (es) 2015-10-20 2018-11-12 Massachusetts Inst Technology Sistemas y metodos para retencion de fluidos en superficie.
CN105456233B (zh) * 2015-11-17 2018-04-24 中国石油大学(华东) 一种高载药量的长效缓释抗菌薄膜及其制备方法
KR102486615B1 (ko) 2017-01-30 2023-01-11 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
US20190344274A1 (en) 2018-03-12 2019-11-14 Massachusetts Institute Of Technology Articles and systems involving reaction products on surfaces and associated methods
CN111842088B (zh) * 2020-07-30 2021-08-10 齐鲁工业大学 一种低电位疏水性多肽单层膜及其制备方法与应用
CN111888525B (zh) * 2020-07-30 2021-08-10 齐鲁工业大学 一种高电位疏水性多肽单层膜及其制备方法与应用
CN111840661B (zh) * 2020-07-30 2021-08-10 齐鲁工业大学 一种高电位超亲水性多肽单层膜及其制备方法与应用
CN114605290B (zh) * 2022-03-03 2023-04-07 浙江大学杭州国际科创中心 一种氨基酸螺旋阵列薄膜及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8704185L (sv) 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
US5138026A (en) * 1989-02-15 1992-08-11 Fuji Photo Film Co., Ltd. Polypeptide thin film
IL103284A0 (en) 1991-10-31 1993-02-21 Transtech Medical Inc Transplant protective coating
US5629213A (en) 1995-03-03 1997-05-13 Kornguth; Steven E. Analytical biosensor
JP2966795B2 (ja) * 1996-09-30 1999-10-25 科学技術振興事業団 機能性薄膜とその製造方法
AU7121198A (en) * 1997-04-18 1998-11-13 California Institute Of Technology Multifunctional polymeric tissue coatings
DE69904307T2 (de) * 1998-03-19 2003-09-04 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Herstellung von mit mehrlagen gestrichenen partikeln und hohlen schalen durch elektrostatische selbstorganisierung von nanokompositmehrlagen auf zersetzbaren schablonen
US7101575B2 (en) * 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6689366B1 (en) 1998-12-17 2004-02-10 Merck & Co., Inc. Synthetic virus like particles with heterologous epitopes
US6833192B1 (en) * 1999-06-10 2004-12-21 Max-Planck Gesellschaft Zur Forderrung Der Wissenschaften E.V. Encapsulation of crystals via multilayer coatings
DE10001172A1 (de) * 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
ES2223914T3 (es) * 2000-08-02 2005-03-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Produccion de capsulas de polielectrolitos mediante precipitacion superficial.
EP1313455B1 (en) * 2000-08-28 2005-05-11 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Controlled and sustained release properties of polyelectrolyte multilayer capsules
AU2001294458B2 (en) * 2000-10-06 2004-03-11 Jagotec Ag Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
FR2823675B1 (fr) * 2001-04-19 2004-03-12 Inst Nat Sante Rech Med Biomateriaux avec recouvrements bioactifs
FR2824756B1 (fr) * 2001-05-16 2005-07-08 Mainelab Microcapsules a base de proteines vegetales
US6689478B2 (en) * 2001-06-21 2004-02-10 Corning Incorporated Polyanion/polycation multilayer film for DNA immobilization
TW200304385A (en) * 2002-03-13 2003-10-01 Novartis Ag Materials containing multiple layers of vesicles
WO2003099835A1 (en) * 2002-05-21 2003-12-04 Emory University Multivalent polymers with chain-terminating binding groups
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
US20050100883A1 (en) 2003-11-12 2005-05-12 Wang Chang Y. Peptide-based diagnostic reagents for SARS
WO2006089572A1 (en) * 2005-02-28 2006-08-31 Charité - Universitätsmedizin Berlin Polyelectrolyte capsules for detecting antigen-antibody-reactions

Also Published As

Publication number Publication date
EP1948696A2 (en) 2008-07-30
AU2006347951B2 (en) 2011-12-22
WO2007050702A2 (en) 2007-05-03
US7786076B2 (en) 2010-08-31
US7807633B2 (en) 2010-10-05
MX2008005364A (es) 2008-11-20
US7807632B2 (en) 2010-10-05
US20100034875A1 (en) 2010-02-11
US20100028410A1 (en) 2010-02-04
CN101365724A (zh) 2009-02-11
CN103357007A (zh) 2013-10-23
CA2627376C (en) 2016-07-05
EP1948695B1 (en) 2012-12-19
WO2007050569A2 (en) 2007-05-03
IL190863A (en) 2011-10-31
AU2006347951A1 (en) 2008-03-13
JP2009513651A (ja) 2009-04-02
IL190885A0 (en) 2008-11-03
WO2007050702A3 (en) 2007-08-16
DK2308900T3 (da) 2014-05-12
IL190863A0 (en) 2008-11-03
ES2400665T3 (es) 2013-04-11
WO2007050569A3 (en) 2007-06-28
CA2632703A1 (en) 2008-03-13
ES2462519T3 (es) 2014-05-23
IL190885A (en) 2011-09-27
EP2308900A2 (en) 2011-04-13
US7781399B2 (en) 2010-08-24
EP2308900A3 (en) 2011-04-20
EP2308900B1 (en) 2014-02-12
WO2008030253A3 (en) 2008-05-29
DK1948695T3 (da) 2013-02-04
CN101296945A (zh) 2008-10-29
US20080020402A1 (en) 2008-01-24
US7807634B2 (en) 2010-10-05
US20100028448A1 (en) 2010-02-04
JP5751741B2 (ja) 2015-07-22
US20100028423A1 (en) 2010-02-04
US20100028424A1 (en) 2010-02-04
WO2008030253A2 (en) 2008-03-13
AU2006306202B2 (en) 2011-12-15
EP1948695A2 (en) 2008-07-30
AU2006306202A1 (en) 2007-05-03
CA2627376A1 (en) 2007-05-03
JP2009513654A (ja) 2009-04-02

Similar Documents

Publication Publication Date Title
MX345029B (es) Composiciones inmunogénicas y métodos de uso.
WO2007021762A3 (en) Methods and materials for fabricating microfluidic devices
WO2008053444A3 (en) Treating a respiratory condition with bifidobacterium
IN2011CN07418A (es)
IN2014DN09616A (es)
ATE526836T1 (de) Nährstoffzusammensetzung mit probiotika
WO2009126292A3 (en) Biologically active peptidomimetic macrocycles
ATE510578T1 (de) Medizinische ballons
WO2007133458A3 (en) Suspended pixelated seating structure
WO2008124647A3 (en) Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
MXPA04005553A (es) Estructuras de pelicula y metodos para elaborar las mismas.
SG160436A1 (en) Polymer interlayers comprising skin layers
MX347189B (es) Bloque de cojin y metodo para manufacturar el mismo.
WO2010096550A3 (en) Lactobacillus supplement for alleviating type 1 diabetes
MX360544B (es) Película de barrera de capas múltiples, laminados y procesos de los mismos.
WO2012021884A3 (en) Photovoltaic device
TWI265864B (en) Hydrophilic surface structure of non-hydrophilic substrate and fabricating method for the same
WO2006121890A3 (en) Medical devices and methods of making the same
WO2014102493A3 (fr) Substrat transparent, notamment substrat verrier, revêtu par au moins une couche poreuse au moins bifonctionnelle, procédé de fabrication et applications
USD660194S1 (en) Diamond
EP2082894A3 (de) Dokument sowie Verfahren zur Herstellung eines Dokumentes
SG160435A1 (en) Polymer interlayers comprising antiblocking layers
DE602005020942D1 (de) Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren
JP2015507560A5 (es)
WO2012047728A3 (en) Barrier film or fabric